Article Details

Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal - Yahoo! Sports

Retrieved on: 2022-08-05 02:46:33

Tags for this article:

Click the tags to see associated articles and topics

Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal - Yahoo! Sports. View article details on hiswai:

Excerpt

... therapies for immune disorders, a field in the spotlight following AstraZeneca's 2020 purchase of Alexion Pharmaceuticals for $39 billion.

Article found on: sports.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up